Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

SC epoetin-alfa cost saving vs IV route in anaemia

    • 10 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    SC epoetin-alfa cost saving vs IV route in anaemia. Pharmacoecon. Outcomes News 383, 6 (2002). https://doi.org/10.1007/BF03279691

    Download citation

    Keywords

    • Cost Saving
    • Outcome News
    • Erythropoietin
    • Hemodialysis Patient
    • Average Dose